InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-03-19 | Richard Dean Dr McCormick(R-GA06) | house | Purchase | $1,001 - $15,000 |
| 2026-03-13 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2026-02-10 | Gilbert Cisneros(D-CA31) | house | Sale | $15,001 - $50,000 |
| 2026-02-05 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2025-12-23 | Kevin Hern(R-OK01) | house | Sale | $250,001 - $500,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Premiums | $352.23B+14.1% | $308.81B+6.2% | $290.83B+13.1% | $257.16B+13.7% | $226.23B |
| Investment and other income | $3.92B-24.6% | $5.20B+27.2% | $4.09B+101.4% | $2.03B-12.7% | $2.32B |
| Total revenues | $447.57B+11.8% | $400.28B+7.7% | $371.62B+14.6% | $324.16B+12.7% | $287.60B |
| Medical costs | $314.00B+18.9% | $264.19B+9.2% | $241.89B+14.7% | $210.84B+12.8% | $186.91B |
| Operating costs | $59.59B+12.4% | $53.01B-3.0% | $54.63B+14.3% | $47.78B+12.2% | $42.58B |
| Cost of products sold | $50.66B+8.5% | $46.69B+20.4% | $38.77B+15.0% | $33.70B+8.6% | $31.03B |
| Depreciation and amortization | $4.36B+6.4% | $4.10B+3.2% | $3.97B+16.8% | $3.40B+9.6% | $3.10B |
| Total operating costs | $428.60B+16.5% | $367.99B+8.5% | $339.26B+14.7% | $295.73B+12.2% | $263.63B |
| Earnings from operations | $18.96B-41.3% | $32.29B-0.2% | $32.36B+13.8% | $28.43B+18.6% | $23.97B |
| Interest expense | -$4.00B-2.5% | -$3.91B-20.3% | -$3.25B-55.2% | -$2.09B-26.0% | -$1.66B |
| Loss on sale of subsidiary and subsidiaries held for sale | -$265.0M+96.8% | -$8.31B | $0 | $0 | — |
| Total income before income taxes | $14.70B-26.8% | $20.07B-31.1% | $29.11B | — | — |
| Provision for income taxes | -$1.89B+60.9% | -$4.83B+19.1% | -$5.97B-4.6% | -$5.70B-24.6% | -$4.58B |
| Net earnings | $12.81B-16.0% | $15.24B-34.1% | $23.14B+12.1% | $20.64B+16.4% | $17.73B |
| Earnings attributable to noncontrolling interests | -$751.0M+10.3% | -$837.0M-9.7% | -$763.0M-47.0% | -$519.0M-16.1% | -$447.0M |
| Net earnings attributable to UnitedHealth Group common shareholders | $12.06B-16.3% | $14.40B-35.6% | $22.38B+11.2% | $20.12B+16.4% | $17.29B |
| Basic | $13.3M-15.1% | $15.6M-35.2% | $24.1M+12.3% | $21.5M+17.1% | $18.3M |
| Diluted | $13.2M-14.7% | $15.5M-35.0% | $23.9M+12.7% | $21.2M+17.1% | $18.1M |
| Basic weighted-average number of common shares outstanding | $908.0M-1.4% | $921.0M-0.8% | $928.0M-1.0% | $937.0M-0.6% | $943.0M |
| Dilutive effect of common share equivalents | $3.0M-62.5% | $8.0M-20.0% | $10.0M-23.1% | $13.0M+0.0% | $13.0M |
| Diluted weighted-average number of common shares outstanding | $911.0M-1.9% | $929.0M-1.0% | $938.0M-1.3% | $950.0M-0.6% | $956.0M |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | $12.0M+100.0% | $6.0M+0.0% | $6.0M+100.0% | $3.0M+200.0% | $1.0M |
| Products | |||||
| Revenue from Products and Services | $38.04B+5.5% | $36.04B+5.6% | $34.12B+23.9% | $27.55B+12.0% | $24.60B |
| Services | |||||
| Revenue from Products and Services | $38.04B+5.5% | $36.04B+5.6% | $34.12B+23.9% | $27.55B+12.0% | $24.60B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
Insider trades: Abbott, UnitedHealth and ServiceNow among notable names
Is It Time To Reassess UnitedHealth Group (UNH) After Its Sharp 30 Day Rally?
SCHD: Go Back To Bed, Why You'll Sleep Well At Night